/ Not yet recruiting临床1期IIT Phase I Clinical Study on the Safety and Tolerability of IASO206 Injection in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection (In Vivo CAR-T) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia
/ Not yet recruiting早期临床1期IIT An Exploratory Study of Safety and Efficacy of IASO206 in Patients With Relapsed/Refractory Multiple Myeloma
This study is an open-label, single-arm early exploratory clinical study, aiming to evaluate the safety, tolerability and preliminary efficacy of IASO206 Injection(In Vivo CAR-T) in Patients with Relapsed/Refractory Multiple Myeloma
100 项与 IASO 206 相关的专利(医药)